{
  "trial_id": "NCT02436655",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "men and women of any ethnic origin aged \u226518 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Written informed consent",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "V max across the aortic valve > 4m/s or Pmean \u2265 40mmHg and AVA \u2264 1cm2 or AVAi \u2264 0.6cm2/m2 at rest",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Participation in another clinical trial within 30 days prior randomization",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Pregnant or nursing women",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "48 M with a h/o HTN hyperlipidemia, bicuspid aortic valve, and tobacco abuse who presented to his cardiologist on [**2148-10-1**] with progressive SOB and LE edema. TTE revealed severe aortic stenosis with worsening LV function. EF was 25%. RV pressure was 41 and had biatrial enlargement. Noted to have 2+ aortic insufficiency with mild MR.",
  "_meta": {
    "topic_id": "2",
    "trial_id": "NCT02436655",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_test10_top50"
  }
}